中國醫藥學院(現中國醫藥大學)醫學系學士 1976~1983
美國路易維爾大學University of Louisville, Louisville KY 微生物免疫學碩士 1986~1989

和信治癌中心醫院 副院長 2022.07~2024.11
和信治癌中心醫院 血液與腫瘤科部 主任 2010.04-2022.06
和信治癌中心醫院 肺癌及食道癌團隊 負責人 1999~2022

中華民國內科醫學會
中華民國癌症醫學會
美國內科醫學會
美國臨床腫瘤醫學會
美國血液學會

• Janckila AJ, Chu NM, Epremian BE. Chronic lymphocytic leukemia with prolymphocytic transformation simulating hairy cell leukemia. J Histotechnology. 1987;10:127-130.
• Chu NM, Janckila AJ, Wallace JH, Yam LT. Assessment of methods for immunochemical detection of antigen on nitrocellulose membranes. J Histochem Cytochem. 1989;37:257-263.
• Marsh R de W, Chu NM. Placental metastasis from primary ocular melanoma: A case report. Am J Obstet Gynecol. 1996;174(5):1654-1655.
• Vauthey JN, Marsh R de W, Cendean JC, Chu NM, Copeland EM. Arterial therapy of hepatic colorectal metastases. Brit J Surg. 1996;93:447-455.
• Marsh R de W, Chu NM, Bauthey JN, Mendenhall W, Bewsher C. Unresectable rectal cancer utilizing continuous chronobiologically shaped 5-FU infusion and radiation therapy. Cancer. 1996;78:217-225.
• Cheng SH, Jian JJ, Tsai SY, Chan KY, Yen LK, Chu NM, Tan TD, Tsou MH, Huang AT. Prognostic Features and Treatment Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma Following Concurrent Chemotherapy and Radiotherapy. Int J Radiation Oncology Biol Phys. 1998;41(4):755-762.
• Cheng SH, Tsai SY, Yen KL, Jian JJ, Chu NM, Chan KY, Tan TD, Cheng JC, Hsieh CY, Huang AT. Concomitant Radiotherapy and Chemotherapy for Early-Stage Nasopharyngeal Carcinoma. J Clin Oncol. 2000;18(10):2040-2045.
• Huang AT, Cheng JC, Jian JJ, Tsou MH, Lin YC, Cheng SH, Leu SY, Tan TD, Lin CY, Hsieh CI, Chan KY, Chu NM, Tsai SY. Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):344-352.
• Huang AT, Jian JJ, Lin YC, Cheng SH, Tan TD, Chan KY, Yen KL, Chu NM, Feng AC, Chong V, Tsai SY, Hong CF, Lin CY, Hsieh CY. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61:456-465.
• Chen JS, Liau CT, Liu HE, Deuson R, Chu NM, Lien J. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians’ and nurses’ estimation vs patients’ reported outcomes. Support Care Cancer. 2005 May;13:277-286.
• Chung YL, Huang AT, Tsou MH, Cheng SH, Tsai SY, Horng CF, Tan TD, Lin CY, Hsieh CI, Chen PL, Chan KY, Jian JJ, Yen KL, Chu NM, Terng SD, Chen HH. A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Sep 15.
• Perng R, Yang C, Chen Y, Chang G, Lin M, Hsieh R, Chu NM, Lai R, Su W, Tsao C. High efficacy of erlotinib in Taiwanese NSCLC patients in an expanded access program study previously treated with chemotherapy. Lung Cancer. 2008;62(1):78-84.
• Hsu LH, Chu NM, Liu CC, Tsai SY, You DL, Ko JS, Lu MC, Feng AC. Sex-associated differences in non-small cell lung cancer in the new era: Is gender an independent prognostic factor? Lung Cancer. 2009;66:262-267.
• Chu NM, Hsieh C, Fang W, Chang S, Chu Z. Reduced vehicle-related side effects of paclitaxel combined with gemcitabine for stage IIIB or IV non-small cell lung cancer: A phase II trial result. ASCO June 2004; P678 (Abs 7620).
• Liau CT, Chu NM, Kiu HE, Yang GY, Deuson R. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: Perception versus reality. ASCO June 2004; P775 (Abs 8200).
• Chu NM, Janckila AJ, Wallace JH, Yam LT. Assessment of enzyme labeling methods in immunoblotting. 8th Int Congress of Histochemistry & Cytochemistry, Washington DC, 1998.
• Marsh R de W, Chu NM, Mendenhall W, Vauthey JN, Copeland EM, Lind ES. Neoadjuvant circadian-shaped 5-FU infusion plus radiation for locally advanced rectal cancer. Proc ASCO May 1995;15:21 (Abs 531).
• Bjarnason G, Marsh R, Chu NM, Hrushesky W, Kerr I. Phase II study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in patients with metastatic colorectal cancer. Proc Int Soc Chronobiology 1995; Abs #3; Proc ASCO May 1996; Abs #543.
• Marsh R de W, Chu NM, Mendenhall W, Vauthey JN, Copeland EM, Lind ES. Neoadjuvant circadian-shaped 5-FU infusion plus radiation for locally advanced rectal cancer. Proc ASCO May 1995;15:21 (Abs 531).
• Comparison of 19-gauge eXcelon and WANG MW-319 transbronchial aspiration needles. Thoracic Cancer. 2015; doi: 10.1111/1759-7714.12301.